Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) shares crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $81.51 and traded as high as $85.51. Henry Schein shares last traded at $84.23, with a volume of 1,904,336 shares traded.
Wall Street Analyst Weigh In
Several research firms recently issued reports on HSIC. Wall Street Zen upgraded Henry Schein from a “hold” rating to a “buy” rating in a report on Monday, August 17th. Citigroup reiterated a “buy” rating and set a $112.00 price target (up from $100.00) on shares of Henry Schein in a research note on Wednesday, August 5th. Barrington Research set a $104.00 price target on shares of Henry Schein in a research report on Wednesday, August 5th. Barclays reissued an “overweight” rating and issued a $100.00 price objective (up from $86.00) on shares of Henry Schein in a research note on Thursday, August 6th. Finally, Stifel Nicolaus set a $95.00 price objective on shares of Henry Schein in a report on Wednesday, August 5th. Nine investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.93.
Check Out Our Latest Research Report on HSIC
Henry Schein Stock Down 1.4%
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.03. Henry Schein had a net margin of 2.96% and a return on equity of 15.97%. The firm had revenue of $3.46 billion for the quarter, compared to analysts’ expectations of $3.37 billion. During the same quarter last year, the company earned $1.10 earnings per share. The firm’s revenue was up 6.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. Research analysts forecast that Henry Schein, Inc. will post 5.36 EPS for the current fiscal year.
Institutional Trading of Henry Schein
A number of institutional investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio purchased a new stake in Henry Schein during the second quarter worth approximately $2,547,000. Buckland Partners Management Co LLC acquired a new position in shares of Henry Schein in the 2nd quarter valued at $1,036,000. Heartland Advisors Inc. purchased a new position in shares of Henry Schein in the 4th quarter valued at $9,070,000. K.J. Harrison & Partners Inc acquired a new stake in Henry Schein during the 1st quarter worth $1,253,000. Finally, California State Teachers Retirement System lifted its position in Henry Schein by 16.3% in the first quarter. California State Teachers Retirement System now owns 123,992 shares of the company’s stock valued at $9,138,000 after acquiring an additional 17,418 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.
About Henry Schein
Henry Schein, Inc (NASDAQ: HSIC) is a global provider of health care products and services serving dental and medical professionals, laboratories, health care institutions and veterinary practices. The company operates primarily as a distributor, helping customers obtain medical, dental and veterinary supplies, equipment, pharmaceuticals and related products.
In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support practice management, clinical workflows, procurement, compliance and business operations.
Recommended Stories
- Five stocks we like better than Henry Schein
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
